Clinical trial

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

NCT00291356

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE2

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2015-04-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Non-Insulin-Dependent Diabetes Mellitusunresolved

Interventions

GSK189075 oral tabletsDRUG

GW869682 oral tabletsDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

Chula VistaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00291356 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.